| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,521 |
5,489 |
$2.05M |
| 96367 |
|
4,328 |
3,574 |
$740K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,661 |
13,938 |
$689K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
536 |
464 |
$349K |
| 99215 |
Prolong outpt/office vis |
5,325 |
4,442 |
$312K |
| 80053 |
Comprehensive metabolic panel |
27,396 |
18,682 |
$222K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,381 |
20,384 |
$161K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
993 |
897 |
$133K |
| 83735 |
|
23,516 |
15,913 |
$121K |
| 83615 |
|
23,329 |
15,830 |
$108K |
| 82977 |
|
15,898 |
10,325 |
$106K |
| 82248 |
|
23,175 |
15,743 |
$89K |
| 84100 |
|
23,381 |
15,849 |
$85K |
| 84550 |
|
23,464 |
15,896 |
$81K |
| 77386 |
|
203 |
61 |
$77K |
| 77014 |
|
536 |
97 |
$61K |
| 74178 |
|
534 |
460 |
$58K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
319 |
280 |
$46K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
672 |
524 |
$31K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,187 |
984 |
$28K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,405 |
1,238 |
$25K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
134 |
124 |
$23K |
| 82728 |
|
2,191 |
1,873 |
$19K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
115 |
98 |
$15K |
| 82607 |
|
1,492 |
1,310 |
$14K |
| 83550 |
|
2,209 |
1,889 |
$12K |
| 82746 |
|
1,309 |
1,140 |
$12K |
| 77427 |
|
91 |
38 |
$10K |
| 77336 |
|
161 |
97 |
$10K |
| 83540 |
|
2,200 |
1,879 |
$9K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
243 |
118 |
$7K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
12 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
27 |
$4K |
| 77334 |
|
27 |
13 |
$3K |
| 70491 |
|
13 |
12 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
4,759 |
3,308 |
$2K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
13 |
12 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,089 |
937 |
$2K |
| 84436 |
|
317 |
275 |
$1K |
| 96417 |
|
12 |
12 |
$1K |
| 82784 |
|
105 |
84 |
$645.84 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
12 |
$609.65 |
| 80050 |
General health panel |
12 |
12 |
$584.04 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
199 |
160 |
$336.27 |
| 82533 |
|
13 |
12 |
$152.72 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
75 |
64 |
$3.18 |
| G9678 |
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement |
245 |
245 |
$0.00 |